Comparative Activities of Novel Therapeutic Agents against Molecularly Characterized Clinical Carbapenem-Resistant Enterobacterales Isolates

Limited treatment options exist for the treatment of carbapenem-resistant Enterobacterales (CRE) bacteria. Fortunately, there are several recently approved antibiotics indicated for CRE infections. Here, we examine the in vitro activity of various novel agents (eravacycline, plazomicin, ceftazidime-...

Descripción completa

Detalles Bibliográficos
Autores principales: Teo, Jocelyn Qi-Min, Chang, Hong Yi, Tan, Si Hui, Tang, Cheng Yee, Ong, Rick Twee-Hee, Ko, Karrie Kwan Ki, Chung, Shimin Jasmine, Tan, Thuan Tong, Kwa, Andrea Lay-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269625/
https://www.ncbi.nlm.nih.gov/pubmed/37184408
http://dx.doi.org/10.1128/spectrum.01002-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269625/
https://www.ncbi.nlm.nih.gov/pubmed/37184408
http://dx.doi.org/10.1128/spectrum.01002-23

Ejemplares similares